
An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …

Eisai and Biogen Idec have joined forces to look for new Alzheimer’s treatments, developing and commercialising two of the Japanese …

